| News for medical technology professionals | December 18, 2008 |
 |
|
 |
-
Looking forward to 2009
 | |
|
Ashley McMaster, Lead Editor
|
Part I of this AdvaMed SmartBrief special year-end report looked back at the most important trends and stories of 2008. Part II, below, highlights several predictions -- including from Edwards Lifesciences Chairman and CEO Michael A. Mussallem and AdvaMed SmartBrief readers -- for what's expected in 2009.From my perspective, the upcoming year will present many challenges and opportunities for the medical-device industry. Medical-technology companies, as well as the FDA, must strive to educate consumers about device-safety procedures and regulations and make sure that compliance and device safety retain the highest priority. In the area of policy, health care reform legislation is likely to gain attention as President-elect Barack Obama and his administration begin their term in January, and the industry should continue to seek reimbursement policies that recognize contributions from new technologies and innovations. As for events, the first half of the year promises the 2009 International Medical Device Industry Compliance, Regulatory & IP Conference in Rome and several Medical Technology Learning Institute seminars in Orlando, Fla. Visit the AdvaMed Web site for full details.
|
|
|
| Your Predictions |  |  |
|
| Do you expect China's recently announced health care reform to affect your business there, either positively or negatively? |
| Yes |
 |
50.88% |
| No |
 |
29.82% |
| Maybe |
 |
19.30% |
| What issue should receive the most attention from the industry in 2009? |
| R&D investments in a strained economy |
 |
42.35% |
| Addressing ethics and compliance concerns |
 |
30.59% |
| Expansion into international markets |
 |
14.12% |
| Mergers and acquisitions |
 |
8.24% |
| Other |
 |
4.71% |
| What do you think was the top issue in the medical technology industry in 2008? |
| Ethics and interactions with physicians |
 |
54.72% |
| Health care reform |
 |
21.70% |
| Comparative effectiveness research (health care costs) |
 |
12.26% |
| Federal pre-emption of PMA products |
 |
7.55% |
| Patent reform |
 |
3.77% |
| The Big Picture |  |  |
|

| | |
Product announcements appearing in SmartBrief are paid advertisements and do not
reflect actual AdvaMed endorsements. The news reported in SmartBrief does not necessarily
reflect the official position of AdvaMed.
|
| |
|
Read more at SmartBrief.com |
|
A powerful Web site for SmartBrief readers including:
|
|
|
|
| |
| |
| | Recent AdvaMed SmartBrief Issues:
- Wednesday, December 17, 2008
- Tuesday, December 16, 2008
- Monday, December 15, 2008
- Friday, December 12, 2008
- Thursday, December 11, 2008
| | | Lead Editor: Ashley McMaster
Mailing Address:
SmartBrief, Inc.®, 1100 H ST NW, Suite 1000, Washington, DC 20005 | |
| |
|
| © 1999-2009 SmartBrief, Inc.® Legal Information |
|